$1.07 0.00 (0.00%) Rosetta Genomics Ltd - NASDAQ

Jul. 27, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 1.07
Trade Time: Jul 27 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 1.07
Open: 1.08
Bid: 1.08
Ask: 1.18
  1. No results found.
  1. Rosetta Genomics Reports Advancement of Collaboration with Biocept for PoC Studies Aimed at microRNA Profiling of Circulating Tumor Cells

    Benzinga | Dec. 14, 2015 | 08:13AM EST
  2. Rosetta Provides Update on Performance Data and Launch of RosettaGX Revealâ„¢ (Thyroid microRNA Classifier)

    Benzinga | Nov. 12, 2015 | 08:58AM EST
  3. Rosetta Genomics to Host Business Update, Six Month Financials Conference Call on October 27, 2015

    Benzinga | Oct. 20, 2015 | 08:33AM EST
  4. Rosetta Genomics Launches BRAF Mutation Assay

    Benzinga | Oct. 12, 2015 | 08:32AM EST
  5. Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services

    Benzinga | Jun. 16, 2015 | 08:31AM EST
  6. Rosetta Genomics Launches Two Assays for Bladder Cancer

    Benzinga | May. 14, 2015 | 08:50AM EST
  7. Benzinga's Top Initiations

    Benzinga | Apr. 30, 2015 | 09:40AM EST
  8. Benzinga's Top Upgrades

    Benzinga | Apr. 17, 2015 | 08:57AM EST
  9. Morning Market Gainers

    Benzinga | Feb. 17, 2015 | 09:43AM EST
  10. Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance

    GuruFocus | Nov. 18, 2014 | 11:04AM EST
  11. Rosetta Genomics' microRNA-Based Assay For Thyroid Cancer Highlighted In Poster Presentation At 84th Annual Meeting Of The American Thyroid Association

    Benzinga | Oct. 23, 2014 | 08:06AM EST
  12. Biocept And Rosetta Genomics Collaborate To Evaluate microRNAs From Circulating Tumor Cells

    Benzinga | Oct. 13, 2014 | 08:31AM EST
  13. Rosetta Genomics Announces Final New York State Approval for Rosetta Kidney Cancer Test

    Benzinga | Jul. 22, 2014 | 09:33AM EST
  14. UPDATE: Barrington Research Initiates Coverage On Rosetta Genomics Ltd. On Good Market Position

    Benzinga | Jun. 4, 2014 | 10:33AM EST
  15. Morning Market Movers

    Benzinga | Jan. 13, 2014 | 09:54AM EST
Trading Center